COVID-19 Rapid Screening in International Airports around the globe.

Virusight Diagnostic is a newly formed Joint Venture of Sheba Medical Center’s ARC Innovation Center & Newsight Imaging. The pilot is due to start at airports in the EU.

In a ground-breaking effort to keep international airports open and providing safe travel for both tourists and business executives in the COVID-19 era, Virusight Diagnostic, a newly formed AI (Artificial Intelligence) healthcare venture between Sheba Medical Center’s ARC Innovation Center and Newsight Imaging, has signed a strategic LOI (letter of intent) for rapid screening of airline passengers with ICTS Europe, a leading security provider at major airports across the globe.

Virusight obtained the rights to use the SpectraLIT™, Newsight Imaging’s portable and accurate spectral analysis device, empowered by Virusight’s software solution combining Machine Learning and Artificial Intelligence. The method has been clinically proven at Sheba Medical Center, the largest hospital in Israel and the Middle East to identify viruses such as COVID-19 in seconds – using a simple oral mouth rinse. The company is now joining forces with ICTS Europe to implement the technology and screen millions of passengers in airports worldwide.

ICTS Europe is an international group with over 30 years’ experience in providing security solutions to organisation within the Aviation, Public Transport, and Corporate sectors. ICTS operates in 23 countries, covering over 120 airports and 300 operation centers across Europe, North America, and the Far East. Read More